Export 16 results:Author Title Type [ Year]
Filters: First Letter Of Last Name is S and Author is L.M Smith [Clear All Filters]
Best practices and benchmarks for intact protein analysis for top-down mass spectrometry. Nature methods. 16(7). 2019.
Comprehensive in vivo identification of the c-Myc mRNA interactome using HyPR-MS. Cold Spring Harbor Laboratory Press.. 2019.
Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database. Journal of Proteome Research. 18(10). 2019.
Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Science advances. 5(5). 2019.
Encrypted Oligonucleotide Arrays for Molecular Authentication. ACS Combinatorial Science.. 2019.
A five-level classification system for proteoform identifications. Nature methods. 16(10). 2019.
HDA9-PWR-HOS15 is a core histone deacetylase complex regulating transcription and development. Plant Physiology. 180(1):342-355.. 2019.
Improved Protein Inference from Multiple Protease Bottom-Up Mass Spectrometry Data. Journal of Proteome Research. 18(9). 2019.
Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms. Analytical Chemistry. 91(17). 2019.
Adaptation of Hybridization Capture of Chromatin-associated Proteins for Proteomics to Mammalian Cells. Journal of Visualized Experiments. (136). 2018.
EBS is a bivalent histone reader that regulates floral phase transition in Arabidopsis. Nature genetics. 50(9). 2018.
Global Identification of Post-Translationally Spliced Peptides with Neo-Fusion. Journal of Proteome Research. 18(1):349-358.. 2018.
HyPR-MS for multiplexed discovery of MALAT1, NEAT1, and NORAD lncRNA protein interactomes. Journal of Proteome Research. 17(9):3022-3038.. 2018.
Identification and quantification of murine mitochondrial proteoforms using an integrated top-down and intact-mass strategy. Journal of Proteome Research. 17(10):3526-3536.. 2018.
Long noncoding RNAs AC009014. 3 and newly discovered XPLAID differentiate aggressive and indolent prostate cancers. Translational Oncology. 11(3):808-814.. 2018.